Elagolix in endometriosis-related pain: a profile of its use as approved in the USA

Condition tags

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (27)

• Baseline Burden of Endometriosis-Associated Pain among Women in Two Phase 3 Elagolix Studies [10Q] via openalex
• Bone turnover changes in women treated with elagolix or placebo during the elaris EM-I and EM-II trials who did not continue in the extension studies via openalex
• Current and Emerging Therapeutics for the Management of Endometriosis via openalex
• Decreased Rescue Analgesic Use with Elagolix Treatment in Women with Endometriosis-Associated Pain [35G] via openalex
• Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study via openalex
• Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density via openalex
• Elagolix, a Novel, Orally Bioavailable GnRH Antagonist under Investigation for the Treatment of Endometriosis-Related Pain via openalex
• Elagolix: First Global Approval via openalex
• Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain via openalex
• Elagolix Reduces Fatigue in Patients With Moderate-to-Severe Endometriosis Pain [34G] via openalex
• Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study via openalex
• Endometriosis via openalex
• Endometriosis: where are we and where are we going? via openalex
• Impact of Elagolix on Health-Related Quality of Life Among Patients with Moderate to Severe Endometriosis-Associated Pain: Analysis of EQ-5D-5L Data from a Phase III Randomized Controlled Trial via openalex
• Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
• Long-Term Outcomes of Elagolix in Women With Endometriosis via openalex
• Population Pharmacokinetics of Elagolix in Healthy Women and Women with Endometriosis via openalex
• Productivity Gains Associated with Treatment with Elagolix For Endometriosis-Associated Pain via openalex
• Quality of sex life in women with endometriosis and deep dyspareunia via openalex
• Reductions in endometriosis-associated pain among elagolix-treated women are consistent across a range of baseline characteristics via openalex
• Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix via openalex
• The direct and indirect costs associated with endometriosis: a systematic literature review via openalex
• The effect of elagolix on the endometrium: safety results from two randomized, placebo-controlled studies in women with endometriosis-associated pain via openalex
• Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
• Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist: Results from a Phase 2, Randomized Controlled Study via openalex
• W2411893516 via openalex
• W2610244466 via openalex

Cited by (2)

• The role of elagolix in ovulation suppression during controlled ovarian stimulation: a retrospective cohort study 2024
• The role of elagolix in the suppression of ovulation in donor oocyte cycles 2023

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00